Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

SELL
$1.8 - $3.61 $4,986 - $9,999
-2,770 Reduced 14.4%
16,471 $34,000
Q2 2023

Aug 23, 2023

BUY
$1.14 - $1.63 $21,934 - $31,362
19,241 New
19,241 $31,000
Q2 2020

Aug 13, 2020

SELL
$6.63 - $12.85 $136,882 - $265,301
-20,646 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$6.94 - $14.42 $143,283 - $297,715
20,646 New
20,646 $170,000
Q4 2017

Feb 14, 2018

SELL
$3.38 - $4.74 $44,112 - $61,861
-13,051 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$3.3 - $4.42 $43,068 - $57,685
13,051
13,051 $58,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $39.8M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.